|
1
|
Bayer HealthCare Pharmaceuticals
|
|
2
|
CanSpeak
|
|
3
|
Ms Kerry Drinkwater
|
|
4
|
Mr John Dowling
|
|
5
|
Mr David Prestridge
|
|
6
|
Mr Paul Hobson
|
|
7
|
Mr Andrew Warden
|
|
8
|
Mr Doug Meiklejohn
|
|
9
|
Ms Jan Darby
|
|
10
|
Mr George Curr
|
|
11
|
Mrs Karen Cowley
|
|
12
|
Mr Janis Kinne
|
|
13
|
Mr Peter Carr
|
|
14
|
Name Withheld
|
|
15
|
Mr Peter Renwick
|
|
16
|
Haematology Society of Australia and New Zealand
|
|
17
|
Mr Michael Cochrane
|
|
18
|
Mr Leroy Lai
|
|
19
|
Mr Jason Noble
|
|
20
|
Capt. Michael Cottell
|
|
21
|
Mr John Perz
|
|
22
|
Mr Mark Usher
|
|
23
|
Mr Ken Young
|
|
24
|
Mr John Betts
|
|
25
|
Ms Lee McKerracher
|
|
26
|
Professor John Zalcberg OAM
|
|
27
|
Mr Michael Armessen
|
|
28
|
Urey Lau
|
|
29
|
Name Withheld
|
|
30
|
Ms Lorraine Hoskin
|
|
31
|
Ms Fanny Lai
|
|
32
|
Mr Luke Boyd
|
|
33
|
Mrs Ligia Matic
|
|
34
|
Mr Geoffrey Olsson
|
|
35
|
Mr Michael East
|
|
36
|
Ms Leah Graeve
|
|
37
|
Ms Lara Chapman
|
|
38
|
Ms Michelle East
|
|
39
|
Miss Natasha Jauncey
|
|
40
|
Name Withheld
|
|
41
|
Mr Peter Brown
|
|
42
|
Ms Jennifer Shepherd
|
|
43
|
Mr Neville Black
|
|
44
|
Ms Tracy Magiatis
|
|
45
|
Ms Kym Short
|
|
46
|
Specialised Therapeutics Australia
|
|
47
|
Mr Trevor Olsson
|
|
48
|
Ms Pauline Grant
|
|
49
|
Cancer Voices Australia (plus a supplementary
submission)
|
|
50
|
Mr Glenn Stoddart
|
|
51
|
Mr Allen Sibley
|
|
52
|
Ms Ashley Jeffery
|
|
53
|
Cancer Drugs Alliance
|
|
54
|
Mr Russell Broadbent
|
|
55
|
John Logan Cancer Treatment Foundation
|
|
56
|
Mr Tony Maxwell (plus three attachments)
|
|
57
|
Mr Allan Davies
|
|
58
|
Mr Alan Barlee
|
|
59
|
Mr Patrick Coughlan
|
|
60
|
Name Withheld
|
|
61
|
Mr Trevor Brown
|
|
62
|
Mr and Mrs Paul and Maureen Thompson
|
|
63
|
Mr Alan Kearon
|
|
64
|
Brain Tumour Alliance Australia Inc
|
|
65
|
Ms Lillian Leigh
|
|
66
|
Dr Janet Wale
|
|
67
|
Name Withheld
|
|
68
|
Mr Bob Schmidt
|
|
69
|
Ms Janet Humphery
|
|
70
|
Mr and Mrs Peter and Eileen Brown
|
|
71
|
Rev Dr Noel Preston AM
|
|
72
|
Ms Chantal Tierney
|
|
73
|
Name Withheld
|
|
74
|
Mr and Mrs David and Pauline Armstrong
|
|
75
|
Ms Anita Rollinson
|
|
76
|
Mr John Shaw
|
|
77
|
Mrs Maureen Meiklejohn
|
|
78
|
Confidential
|
|
79
|
Mrs Jill Delahoy
|
|
80
|
Ms Linda Wilson
|
|
81
|
Mr Darren Smith
|
|
82
|
Ms Gail McGuiness
|
|
83
|
Palliative Care Australia
|
|
84
|
Ms Helen Scalzo
|
|
85
|
Ms Jennifer Litsas
|
|
86
|
Ms Louise Manoe
|
|
87
|
Novartis Oncology
|
|
88
|
CanSpeak Queensland
|
|
89
|
Confidential
|
|
90
|
Breast Cancer Network Australia
|
|
91
|
Mr Duncan Mitchell
|
|
92
|
Rare Cancers Australia (plus an attachment)
|
|
93
|
Ms Josie Muller
|
|
94
|
Mrs Claire Murnane
|
|
95
|
Ms Sharon Ryan
|
|
96
|
Ms Elizabeth Olsson
|
|
97
|
Ms Marion Davis
|
|
98
|
Ms Maureen Austin
|
|
99
|
Ms Tereena Cocks
|
|
100
|
Mr Damian Lech
|
|
101
|
Ms Catherine Arena
|
|
102
|
Name Withheld
|
|
103
|
Geelong Prostate Support Group
|
|
104
|
Mr Scott Beyer
|
|
105
|
Advanced Prostate Cancer Support Group
|
|
106
|
Mr Jim Marshall
|
|
107
|
Name Withheld
|
|
108
|
Medical Oncology Group of Australia
|
|
109
|
AbbVie
|
|
110
|
Mrs Joanne Wills
|
|
111
|
Mr Michael Cook
|
|
112
|
Society of Hospital Pharmacists of Australia
|
|
113
|
Ms Lesley Royle
|
|
114
|
Roche
|
|
115
|
Name Withheld
|
|
116
|
Melanoma Patients Australia
|
|
117
|
Private Cancer Physicians of Australia Limited
|
|
118
|
Merck Serono Australia
|
|
119
|
Amgen Australia Pty Ltd
|
|
120
|
Merck Sharp and Dohme Australia (plus two attachments
and a supplementary submission)
|
|
121
|
Pfizer Australia
|
|
122
|
Takeda Pharmaceuticals Australia
|
|
123
|
Leukaemia Foundation of Australia
|
|
124
|
Mr and Mrs Gerald and Suzanne Whitty
|
|
125
|
Link Healthcare
|
|
126
|
GI Cancer Institute Consumer Advisory Panel
|
|
127
|
Mr Eric South
|
|
128
|
Dr Agnes Vitry
|
|
129
|
Mrs Laura Carrington
|
|
130
|
The Unicorn Foundation
|
|
131
|
Gilead Sciences (plus a supplementary submission)
|
|
132
|
IVD Australia
|
|
133
|
Mr Terry Crook
|
|
134
|
Mr Ray Chilton
|
|
135
|
Dr Ian Musgrave
|
|
136
|
Ms Cindy Davenport
|
|
137
|
Ovarian Cancer Australia
|
|
138
|
Bristol-Myers Squibb
|
|
139
|
Ms Jolanda Visser
|
|
140
|
Janssen-Cilag Pty Ltd (plus a supplementary submission)
|
|
141
|
Ms Cathy Watt
|
|
142
|
Medicines Australia (plus two attachments and a supplementary
submission)
|
|
143
|
Mrs Karen van Gorp
|
|
144
|
Australian Melanoma Consumer Alliance
|
|
145
|
Cancer Council Australia and Clinical Oncology Society of
Australia
|
|
146
|
CanTeen
|
|
147
|
Novo Nordisk
|
|
148
|
Mr Wallace Donald
|
|
149
|
Bowel Cancer Australia
|
|
150
|
Cancer Voices South Australia
|
|
151
|
Cancer Action Victoria Inc
|
|
152
|
Australian and New Zealand Children's Haematology Oncology
Group (plus a supplementary submission)
|
|
153
|
Dr James McIntosh
|
|
154
|
Name Withheld
|
|
155
|
Ms Roselyn King
|
|
156
|
Mrs Lesley Hondrakis
|
|
157
|
Ms Caeleigh Hancock
|
|
158
|
Hepatitis Australia
|
|
159
|
Australasian Leukaemia and Lymphoma Group
|
|
160
|
Ms Tess Hemeter
|
|
161
|
Mr Rob Royle
|
|
162
|
Ms Monique Prior
|
|
163
|
Ms Kelly Hill
|
|
164
|
Mr Malcolm Trim
|
|
165
|
Ms Fiona Jewell
|
|
166
|
Genomics For Life
|
|
167
|
Lymphoma Australia
|
|
168
|
Mr Graham Evans
|
|
169
|
Mr Richard Harrison
|
|
170
|
Mr David Simcox
|
|
171
|
Ms Kim Watts
|
|
172
|
Mr Mark Haspels
|
|
173
|
Ms Teresa Cilona
|
|
174
|
Mr Jim Gruchy
|
|
175
|
Ms Nathalie Cook
|
|
176
|
Pharmaceutical Society of Australia
|
|
177
|
Dr Scott Chapman
|
|
178
|
Ms Allison McMaster
|
|
179
|
Ms Kate McIntosh
|
|
180
|
Ms Jane Casey
|
|
181
|
Mrs Anna Hickey
|
|
182
|
Mr Trevor Stenner
|
|
183
|
Australian Institute of Health and Welfare
|
|
184
|
Meni Stefanovski
|
|
185
|
Ms Deb Twomey
|
|
186
|
Ms Irene Ormsby
|
|
187
|
Cure Brain Cancer Foundation
|
|
188
|
Tasmanian Government Department of Health and Human
Services
|
|
189
|
Mr Laurance Cook
|
|
190
|
Consumers Health Forum of Australia
|
|
191
|
Eli Lilly Australia
|
|
192
|
The Kids’ Cancer Project
|
|
193
|
Generic Medicines Industry Association
|
|
194
|
Ms Elizabeth Smith
|
|
195
|
Mr Temple Kehoe
|
|
196
|
Pharmaceutical Benefits Advisory Committee
|
|
197
|
Australian Government Department of Health
|
|
198
|
Mr Peter Jones
|
|
199
|
Australian Melanoma Research Foundation
|
|
200
|
Name Withheld
|
|
201
|
Mr Matthew Storey
|
|
202
|
Name Withheld
|
|
203
|
Cancer Council Victoria's Clinical Network
|
|
204
|
Mr Brian Pound
|
|
205
|
Ms Angela Willett
|
|
1
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Advanced Prostate Cancer Support Groups, 24 April 2015
|
|
2
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Roche, 6 May 2015
|
|
3
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Australian Melanoma Research Foundation, 15 May 2015
|
|
4
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Cancer Drugs Alliance, 19 May 2015
|
|
5
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Novartis Oncology, 21 May 2015
|
|
6
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Ovarian Cancer Australia, 22 May 2015
|
|
7
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Clinical Oncology Society of Australia, 22 May 2015
|
|
8
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Leukaemia Foundation of Australia, 22 May 2015
|
|
9
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Society of Hospital Pharmacists of Australia, 22 May
2015
|
|
10
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Australian and New Zealand Children’s Haematology and
Oncology Group, 22 May 2015
|
|
11
|
Answers to Questions taken on Notice during 20 April public
hearing, received from CanTeen, 22 May 2015
|
|
12
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Private Cancer Physicians of Australia, 22 May 2015
|
|
13
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Merck Sharp and Dohme, 24 May 2015
|
|
14
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Medicines Australia, 25 May 2015
|
|
15
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Unicorn Foundation, 25 May 2015
|
|
16
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Pharmaceutical Benefits Advisory Committee, 28 May
2015
|
|
17
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Merck Sharp and Dohme, 28 May 2015
|
|
18
|
Answers to Written Questions on Notice, received from NHS
England, 16 June 2015
|
|
19
|
Answers to Questions taken on Notice during 20 April public
hearing, received from Department of Health, 5 August 2015
|